StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

PMV Pharmaceuticals's total assets was $82.07M at Jun 30, 2026. For fiscal 2025 it was $116.56M, down 39.1% from the year before. The highest annual figure on record is $365.53M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$116.56M-39.1%
FY2024Dec 31, 2024$191.29M-24.1%
FY2023Dec 31, 2023$252.15M-6.7%
FY2022Dec 31, 2022$270.31M-18.5%
FY2021Dec 31, 2021$331.57M-9.3%
FY2020Dec 31, 2020$365.53M+254.8%
FY2019Dec 31, 2019$103.03M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$82.07M-46.3%
Q1 FY2026Mar 31, 2026$96.56M-43.4%
Q4 FY2025Dec 31, 2025$116.56M-39.1%
Q3 FY2025Sep 30, 2025$133.84M-40.1%
Q2 FY2025Jun 30, 2025$152.86M-35.7%
Q1 FY2025Mar 31, 2025$170.61M-28.0%
Q4 FY2024Dec 31, 2024$191.29M-24.1%
Q3 FY2024Sep 30, 2024$223.50M-14.4%
Q2 FY2024Jun 30, 2024$237.54M-1.9%
Q1 FY2024Mar 31, 2024$236.88M-6.7%
Q4 FY2023Dec 31, 2023$252.15M-6.7%
Q3 FY2023Sep 30, 2023$261.03M-8.4%
Q2 FY2023Jun 30, 2023$242.22M-19.4%
Q1 FY2023Mar 31, 2023$253.96M-19.4%
Q4 FY2022Dec 31, 2022$270.31M-18.5%
Q3 FY2022Sep 30, 2022$284.98M-17.2%
Q2 FY2022Jun 30, 2022$300.56M-15.6%
Q1 FY2022Mar 31, 2022$315.01M-11.1%
Q4 FY2021Dec 31, 2021$331.57M-9.3%
Q3 FY2021Sep 30, 2021$344.18M-8.1%
Q2 FY2021Jun 30, 2021$355.91M+245.4%
Q1 FY2021Mar 31, 2021$354.39M–
Q4 FY2020Dec 31, 2020$365.53M–
Q3 FY2020Sep 30, 2020$374.45M–
Q4 FY2019Dec 31, 2019$103.03M–

More PMV Pharmaceuticals figures

See a number that looks wrong?